Michael B. Mccallister net worth and biography

Michael Mccallister Biography and Net Worth

Director of Zoetis

Mr. McCallister provides deep and pragmatic expertise in strategic planning, leadership and stability, management of complex issues and digital transformation from his senior executive leadership roles at Humana, a leading health and welfare services company. He has a proven track record of driving innovation-focused growth, leading strategic M&A initiatives and contributing valuable operational expertise. He also brings extensive corporate governance acumen acquired through his prior and current service on prominent public company boards.

As Chief Executive Officer of Humana, guided the company through significant expansion, responsible for the company’s market capitalization increase from approximately $1.1 billion in 2000 to approximately $12.7 billion at the time of his retirement in 2012.

At Humana, championed digital healthcare management systems, actionable information and customer-centric healthcare plans to deliver affordable and superior health-plan experiences, repositioning the company as an industry leader nationwide.

Brings deep experience driving growth through strategic investments, having overseen major acquisitions such as CarePlus Health Plans and Concentra Inc., which expanded Humana’s core business, adding over 300 medical centers in 42 states and $800 million in annual revenue.

Extensive board experience having formerly served on the board of directors of National City Corp. and on the board of the Business Roundtable, where he was Chairman of its Health and Retirement Task Force.

What is Michael B. Mccallister's net worth?: The estimated net worth of Michael B. Mccallister is at least $1.85 million as of May 11th, 2026. Mccallister owns 24,524 shares of Zoetis stock worth more than $1,851,587 as of May 13th. This net worth approximation does not reflect any other assets that Mccallister may own. Learn More about Michael B. Mccallister's net worth.
How do I contact Michael B. Mccallister?: The corporate mailing address for Mccallister and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Michael B. Mccallister's contact information.
Has Michael B. Mccallister been buying or selling shares of Zoetis?: Within the last three months, Michael B. Mccallister has bought $233,280.00 in shares of Zoetis stock. Most recently, on Monday, May 11th, Michael B. Mccallister bought 3,000 shares of Zoetis stock. The stock was acquired at an average cost of $77.76 per share, with a total value of $233,280.00. Following the completion of the transaction, the director now directly owns 24,524 shares of the company's stock, valued at $1,906,986.24. Learn More on Michael B. Mccallister's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Michael Mccallister (Director), Gregory Norden (Director), Kristin Peck (CEO & Director), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, Zoetis insiders bought shares 1 times. They purchased a total of 3,000 shares worth more than $233,280.00. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 652 shares worth more than $110,840.00. The most recent insider tranaction occured on May, 11th when Director Michael B Mccallister bought 3,000 shares worth more than $233,280.00. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 5/11/2026.

Michael B. Mccallister Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/11/2026	Buy	3,000	$77.76	$233,280.00	24,524
9/6/2016	Buy	2,000	$51.34	$102,680.00

Michael B. Mccallister Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $75.86

$74.88

$77.84

50 Day Range

MA: $115.42

$76.62

$128.95

2 Week Range

Now: $75.86

$74.88

$172.23

Volume

6,230,887 shs

Average Volume

4,889,629 shs

Market Capitalization

$31.80 billion

P/E Ratio

12.58

Dividend Yield

2.77%

Beta

0.87